LTBR and medical procedure: Moreover, the observed overexpression of NF-κΒ2 in NSCLC is consistent with the overexpression of the TNF receptor family member, LTβR (lymphotoxin-β receptor), that occurs in 87 to 96% of a wide range of solid tumors, including lung cancert21,31.